Viridian Therapeutics, Inc./DE Increase (Decrease) in Accrued Liabilities
Viridian Therapeutics, Inc./DE (VRDN) reported Increase (Decrease) in Accrued Liabilities of -$17.57 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2026-08-06
- Viridian Therapeutics, Inc./DE increase (decrease) in accrued liabilities for the quarter ending 2026-06-30 was $6.11M, a 1.15% decline year-over-year.
- Viridian Therapeutics, Inc./DE increase (decrease) in accrued liabilities for the quarter ending 2026-03-31 was -$23.69M.
- Viridian Therapeutics, Inc./DE increase (decrease) in accrued liabilities for the quarter ending 2025-12-31 was $21.32M, a 97.50% increase year-over-year.
- Viridian Therapeutics, Inc./DE increase (decrease) in accrued liabilities for the quarter ending 2025-09-30 was $4.61M, a 18.07% increase year-over-year.
- Viridian Therapeutics, Inc./DE increase (decrease) in accrued liabilities for fiscal 2025 was $16.21M, a 24.04% decline from fiscal 2024.
- Viridian Therapeutics, Inc./DE increase (decrease) in accrued liabilities for fiscal 2024 was $21.34M, a 351.86% increase from fiscal 2023.
- Viridian Therapeutics, Inc./DE increase (decrease) in accrued liabilities for fiscal 2023 was $4.72M, a 38.80% decline from fiscal 2022.
- Viridian Therapeutics, Inc./DE increase (decrease) in accrued liabilities for fiscal 2022 was $7.72M, a 459.13% increase from fiscal 2021.
| Period end | Increase (Decrease) in Accrued Liabilities 3 month | Increase (Decrease) in Accrued Liabilities 3 month as first filed | Increase (Decrease) in Accrued Liabilities 6 month | Increase (Decrease) in Accrued Liabilities 9 month | Increase (Decrease) in Accrued Liabilities 9 month as first filed | Increase (Decrease) in Accrued Liabilities 12 month | Increase (Decrease) in Accrued Liabilities 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $6.11M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$17.57M 10-Q · filed 2026-08-06 | $3.74M derived: sum of 3 quarters · filed 2026-08-06 | $8.36M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2026-03-31 | -$23.69M 10-Q · filed 2026-05-05 | -$2.37M derived: sum of 2 quarters · filed 2026-05-05 | $2.24M derived: sum of 3 quarters · filed 2026-05-05 | $8.43M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2025-12-31 | $21.32M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $25.93M derived: sum of 2 quarters · filed 2026-02-26 | $32.11M derived: sum of 3 quarters · filed 2026-08-06 | $16.21M 10-K · filed 2026-02-26 | |||
| 2025-09-30 | $4.61M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $10.80M derived: sum of 2 quarters · filed 2026-08-06 | -$5.11M 10-Q · filed 2025-11-05 | $5.68M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2025-06-30 | $6.18M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$9.72M 10-Q · filed 2026-08-06 | $1.07M derived: sum of 3 quarters · filed 2026-08-06 | $4.98M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2025-03-31 | -$15.90M 10-Q · filed 2026-05-05 | -$15.83M 10-Q · filed 2025-05-06 | -$5.11M derived: sum of 2 quarters · filed 2026-05-05 | -$1.21M derived: sum of 3 quarters · filed 2026-05-05 | $6.33M derived: sum of 4 quarters · filed 2026-05-05 | ||
| 2024-12-31 | $10.79M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $14.70M derived: sum of 2 quarters · filed 2026-02-26 | $22.23M derived: sum of 3 quarters · filed 2026-02-26 | $21.34M 10-K · filed 2026-02-26 | $21.63M 10-K · filed 2025-03-03 | ||
| 2024-09-30 | $3.91M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $11.44M derived: sum of 2 quarters · filed 2025-11-05 | $10.54M 10-Q · filed 2025-11-05 | $10.76M 10-Q · filed 2024-11-12 | $15.08M derived: sum of 4 quarters · filed 2026-02-26 | ||
| 2024-06-30 | $7.53M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $6.64M 10-Q · filed 2025-08-06 | $11.17M derived: sum of 3 quarters · filed 2026-02-26 | $6.14M derived: sum of 4 quarters · filed 2026-02-26 | |||
| 2024-03-31 | -$894.00K 10-Q · filed 2025-05-06 | $3.64M derived: sum of 2 quarters · filed 2026-02-26 | -$1.39M derived: sum of 3 quarters · filed 2026-02-26 | $1.25M derived: sum of 4 quarters · filed 2026-02-26 | |||
| 2023-12-31 | $4.53M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$497.00K derived: sum of 2 quarters · filed 2026-02-26 | $2.15M derived: sum of 3 quarters · filed 2026-02-26 | $4.72M 10-K · filed 2026-02-26 | $5.01M 10-K · filed 2024-02-27 | ||
| 2023-09-30 | -$5.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$2.39M derived: sum of 2 quarters · filed 2024-11-12 | $188.00K 10-Q · filed 2024-11-12 | $6.19M derived: sum of 4 quarters · filed 2025-03-03 | |||
| 2023-06-30 | $2.64M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $5.22M 10-Q · filed 2024-08-08 | $11.22M derived: sum of 3 quarters · filed 2025-03-03 | $6.97M derived: sum of 4 quarters · filed 2025-03-03 | |||
| 2023-03-31 | $2.58M 10-Q · filed 2024-05-08 | -$72.00K 10-Q · filed 2023-05-10 | $8.58M derived: sum of 2 quarters · filed 2025-03-03 | $4.33M derived: sum of 3 quarters · filed 2025-03-03 | $9.81M derived: sum of 4 quarters · filed 2025-03-03 | ||
| 2022-12-31 | $6.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $1.75M derived: sum of 2 quarters · filed 2025-03-03 | $7.23M derived: sum of 3 quarters · filed 2025-03-03 | $7.72M 10-K · filed 2025-03-03 | |||
| 2022-09-30 | -$4.25M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $1.23M derived: sum of 2 quarters · filed 2023-11-13 | $1.71M 10-Q · filed 2023-11-13 | $3.34M derived: sum of 4 quarters · filed 2024-02-27 | |||
| 2022-06-30 | $5.48M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $5.96M 10-Q · filed 2023-08-08 | $7.59M derived: sum of 3 quarters · filed 2024-02-27 | $1.66M derived: sum of 4 quarters · filed 2024-02-27 | |||
| 2022-03-31 | $483.00K 10-Q · filed 2023-05-10 | $2.11M derived: sum of 2 quarters · filed 2024-02-27 | -$3.82M derived: sum of 3 quarters · filed 2024-02-27 | -$1.30M derived: sum of 4 quarters · filed 2024-02-27 | |||
| 2021-12-31 | $1.63M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | -$4.30M derived: sum of 2 quarters · filed 2024-02-27 | -$1.78M derived: sum of 3 quarters · filed 2024-02-27 | $1.38M 10-K · filed 2024-02-27 | |||
| 2021-09-30 | -$5.93M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$3.41M derived: sum of 2 quarters · filed 2022-11-14 | -$246.00K 10-Q · filed 2022-11-14 | $7.59M derived: sum of 4 quarters · filed 2022-11-14 | |||
| 2021-06-30 | $2.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $5.68M 10-Q · filed 2022-08-15 | $13.52M derived: sum of 3 quarters · filed 2022-08-15 | $13.11M derived: sum of 4 quarters · filed 2022-08-15 | |||
| 2021-03-31 | $3.16M 10-Q · filed 2022-05-13 | $11.00M derived: sum of 2 quarters · filed 2022-05-13 | $10.58M derived: sum of 3 quarters · filed 2022-05-13 | $10.42M derived: sum of 4 quarters · filed 2022-05-13 | |||
| 2020-12-31 | $7.84M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | $7.42M derived: sum of 2 quarters · filed 2022-03-11 | $7.26M derived: sum of 3 quarters · filed 2022-03-11 | $5.01M 10-K · filed 2022-03-11 | |||
| 2020-09-30 | -$414.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05 | -$581.00K derived: sum of 2 quarters · filed 2021-11-05 | -$2.83M 10-Q · filed 2021-11-05 | -$2.67M derived: sum of 4 quarters · filed 2021-11-05 | |||
| 2020-06-30 | -$167.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | -$2.41M 10-Q · filed 2021-08-12 | -$2.25M derived: sum of 3 quarters · filed 2021-08-12 | -$1.36M derived: sum of 4 quarters · filed 2021-08-12 | |||
| 2020-03-31 | -$2.25M 10-Q · filed 2021-05-07 | -$2.08M derived: sum of 2 quarters · filed 2021-05-07 | -$1.19M derived: sum of 3 quarters · filed 2021-05-07 | -$312.00K derived: sum of 4 quarters · filed 2021-05-07 | |||
| 2019-12-31 | $161.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-26 | $1.06M derived: sum of 2 quarters · filed 2021-03-26 | $1.93M derived: sum of 3 quarters · filed 2021-03-26 | $1.08M 10-K · filed 2021-03-26 | |||
| 2019-09-30 | $895.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $1.77M derived: sum of 2 quarters · filed 2020-11-12 | $923.00K 10-Q · filed 2020-11-12 | $433.00K derived: sum of 4 quarters · filed 2020-11-12 | |||
| 2019-06-30 | $877.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $28.00K 10-Q · filed 2020-08-05 | -$462.00K derived: sum of 3 quarters · filed 2020-08-05 | $318.00K derived: sum of 4 quarters · filed 2020-08-05 | |||
| 2019-03-31 | -$849.00K 10-Q · filed 2020-05-08 | -$1.34M derived: sum of 2 quarters · filed 2020-05-08 | -$559.00K derived: sum of 3 quarters · filed 2020-05-08 | -$423.00K derived: sum of 4 quarters · filed 2020-05-08 | |||
| 2018-12-31 | -$490.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13 | $290.00K derived: sum of 2 quarters · filed 2020-03-13 | $426.00K derived: sum of 3 quarters · filed 2020-03-13 | $791.00K 10-K · filed 2020-03-13 | |||
| 2018-09-30 | $780.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | $916.00K derived: sum of 2 quarters · filed 2019-11-08 | $1.28M 10-Q · filed 2019-11-08 | -$53.00K derived: sum of 4 quarters · filed 2019-11-08 | |||
| 2018-06-30 | $136.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $501.00K 10-Q · filed 2019-08-08 | -$833.00K derived: sum of 3 quarters · filed 2019-08-08 | -$697.00K derived: sum of 4 quarters · filed 2019-08-08 | |||
| 2018-03-31 | $365.00K 10-Q · filed 2019-05-09 | -$969.00K derived: sum of 2 quarters · filed 2019-05-09 | -$833.00K derived: sum of 3 quarters · filed 2019-05-09 | -$786.00K derived: sum of 4 quarters · filed 2019-05-09 | |||
| 2017-12-31 | -$1.33M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | -$1.20M derived: sum of 2 quarters · filed 2019-03-14 | -$1.15M derived: sum of 3 quarters · filed 2019-03-14 | -$2.21M 10-K · filed 2019-03-14 | |||
| 2017-09-30 | $136.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $183.00K derived: sum of 2 quarters · filed 2018-11-07 | -$871.00K 10-Q · filed 2018-11-07 | $447.00K derived: sum of 4 quarters · filed 2018-11-07 | |||
| 2017-06-30 | $47.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | -$1.01M 10-Q · filed 2018-08-08 | $311.00K derived: sum of 3 quarters · filed 2018-08-08 | $1.69M derived: sum of 4 quarters · filed 2018-08-08 | |||
| 2017-03-31 | -$1.05M 10-Q · filed 2018-05-09 | $264.00K derived: sum of 2 quarters · filed 2018-05-09 | $1.64M derived: sum of 3 quarters · filed 2018-05-09 | $1.93M derived: sum of 4 quarters · filed 2018-05-09 | |||
| 2016-12-31 | $1.32M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | $2.70M derived: sum of 2 quarters · filed 2018-03-15 | $2.98M derived: sum of 3 quarters · filed 2018-03-15 | $2.21M 10-K · filed 2018-03-15 | |||
| 2016-09-30 | $1.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $1.66M derived: sum of 2 quarters · filed 2017-11-09 | $893.00K 10-Q · filed 2017-11-09 | ||||
| 2016-06-30 | $284.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-11 | -$487.00K 10-Q · filed 2017-08-11 | |||||
| 2016-03-31 | -$771.00K 10-Q · filed 2017-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 | |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |